Literature DB >> 14668096

Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris.

Ali Ozeren1, Mustafa Aydin, Mehmet Tokac, Nejat Demircan, Murat Unalacak, Ahmet Gurel, Mehmet Yazici.   

Abstract

OBJECTIVES: Inflammation is the most important mechanism of plaque disruption playing an essential role in acute coronary syndromes. It is controversial whether the inflammatory mediators are the cause or the result in the development of plaque rupture. Stimulation of interleukins increases adhesion molecules, fibrinogen and plasminogen activator inhibitors,which cause the activation of inflammation and thrombosis. However, the importance of interleukins in acute coronary syndromes has not been clearly defined. We did not find any article concerning relations between the levels of serum interleukin(IL)-1beta, IL-2, IL -8 and tumor necrosis factor (TNF)-alpha in patients with unstable angina pectoris (UAP). So the aim of this study was to determine the levels of serum I -1b, IL-2, IL-8 and TNF-alpha during the early stage of UAP. METHODS AND
RESULTS: Thirty-seven patients with UAP(12 females and 25 males; mean age, 57.5 +/- 9.7 years) within 6 h of admission and 20 healthy volunteers(eight females and 12 males; mean age, 51.3 +/- 6.3 years) were included in the study. IL-1beta, IL-2, IL-8 and TNF-alpha levels were measured using the enzyme-linked immunosorbent assay method. Patients with acute or chronic inflammation, renal failure or chronic heart failure were excluded from the study. The age, gender and risk factors of the study and control groups were similar. The levels of IL-1beta, IL-8 and TNF-alpha were significantly increased (p < /0.0001, p < /0.001 and p < /0.016, respectively) in patients with UAP. There was no difference of IL-2 levels between the UAP group and controls.
CONCLUSION: We detected high levels of IL-1beta, IL-8 and TNF-alpha in patients with UAP during early phase. We suggest that proinflammatory cytokines (e.g. IL-1beta,IL-8, TNF-alpha) may play an important role in the development of atherosclerosis and its complications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668096      PMCID: PMC1781634          DOI: 10.1080/09629350310001633360

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  26 in total

Review 1.  Cellular adhesion molecules and atherogenesis.

Authors:  D T Price; J Loscalzo
Journal:  Am J Med       Date:  1999-07       Impact factor: 4.965

Review 2.  Atherosclerosis is an inflammatory disease.

Authors:  R Ross
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

3.  Interleukin-1 beta in coronary arteries of patients with ischemic heart disease.

Authors:  J Galea; J Armstrong; P Gadsdon; H Holden; S E Francis; C M Holt
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-08       Impact factor: 8.311

Review 4.  Haemostatic risk factors for cardiovascular diseases.

Authors:  W Koenig
Journal:  Eur Heart J       Date:  1998-04       Impact factor: 29.983

5.  Mechanisms modifying atherosclerotic disease - from lipids to vascular biology.

Authors:  P Weissberg
Journal:  Atherosclerosis       Date:  1999-09-09       Impact factor: 5.162

6.  C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris.

Authors:  H Koukkunen; K Penttilä; A Kemppainen; M Halinen; I Penttila; T Rantanen; K Pyörälä
Journal:  Ann Med       Date:  2001-02       Impact factor: 4.709

7.  LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules.

Authors:  G van Willigen; G Gorter; J W Akkerman
Journal:  Arterioscler Thromb       Date:  1994-01

8.  Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction.

Authors:  D Li; L Zhao; M Liu; X Du; W Ding; J Zhang; J L Mehta
Journal:  Am Heart J       Date:  1999-06       Impact factor: 4.749

9.  Systemic inflammatory responses in acute coronary syndrome: increased activity observed in polymorphonuclear leukocytes but not T lymphocytes.

Authors:  S Takeshita; T Isshiki; M Ochiai; T Ishikawa; Y Nishiyama; T Fusano; H Toyoizumi; K Kondo; Y Ono; T Sato
Journal:  Atherosclerosis       Date:  1997-12       Impact factor: 5.162

10.  Elevated plasma levels of interleukin-2 and soluble IL-2 receptor in ischemic heart disease.

Authors:  A D Simon; S Yazdani; W Wang; A Schwartz; L E Rabbani
Journal:  Clin Cardiol       Date:  2001-03       Impact factor: 2.882

View more
  16 in total

1.  The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

2.  Vascular function and inflammation in rheumatoid arthritis: the role of physical activity.

Authors:  George S Metsios; Antonios Stavropoulos-Kalinoglou; Aamer Sandoo; Jet J C S Veldhuijzen van Zanten; Tracey E Toms; Holly John; George D Kitas
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

Review 3.  Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.

Authors:  Greta Wozniak; Aikaterini Toska; Maria Saridi; Odysseas Mouzas
Journal:  Med Sci Monit       Date:  2011-09

4.  High cholesterol diet induces IL-1β expression in adult but not larval zebrafish.

Authors:  Yina Yoon; Jihye Yoon; Man-Young Jang; Yirang Na; Youngho Ko; Jae-Hoon Choi; Seung Hyeok Seok
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

5.  The levels of tumor necrosis factor-alpha and interleukin-6 in patients with isolated coronary artery ectasia.

Authors:  Mustafa Aydin; Ishak Ozel Tekin; Sait Mesut Dogan; Nesligul Yildirim; Mehmet Arasli; Muhammet Rasit Sayin; Ziyaettin Aktop
Journal:  Mediators Inflamm       Date:  2009-06-17       Impact factor: 4.711

6.  A Systems Biology Approach to Characterize Biomarkers for Blood Stasis Syndrome of Unstable Angina Patients by Integrating MicroRNA and Messenger RNA Expression Profiling.

Authors:  Jie Wang; Gui Yu
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-14       Impact factor: 2.629

7.  Increased expression of chitinase 3-like 1 in aorta of patients with atherosclerosis and suppression of atherosclerosis in apolipoprotein E-knockout mice by chitinase 3-like 1 gene silencing.

Authors:  Zushun Gong; Shanshan Xing; Fei Zheng; Qichong Xing
Journal:  Mediators Inflamm       Date:  2014-03-04       Impact factor: 4.711

8.  Higher carbohydrate antigen 125 levels are associated with increased risk of coronary heart disease in elderly chinese: a population-based case-control study.

Authors:  Xiaorong Li; Meian He; Jiang Zhu; Ping Yao; Xiulou Li; Jing Yuan; Xinwen Min; Mingjian Lang; Handong Yang; Frank B Hu; Tangchun Wu; Sheng Wei
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

9.  Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity.

Authors:  Janette Bester; Etheresia Pretorius
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

10.  Effect of Compound Chuanxiong Capsule on Inflammatory Reaction and PI3K/Akt/NF-κB Signaling Pathway in Atherosclerosis.

Authors:  Qunfu Kang; Weihong Liu; Hongxu Liu; Mingxue Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.